Posts in category Most Popular


4Q Update: Sophiris Bio Inc (SPHS) Gets A Buy From Maxim

Maxim analyst Jason Kolbert was out with a research note on Sophiris Bio Inc (NASDAQ:SPHS), following the …

Read more

Valeant Pharmaceuticals Intl Inc (VRX) Refinancing Leads to Price Target Cut, But Value Remains

RBC Capital analyst Douglas Miehm weighed in on Valeant Pharmaceuticals Intl Inc (NYSE:VRX), after the struggling drug …

Read more

Tesla Inc (TSLA) Still Carries Considerable Risk, Amazon.com, Inc.’s (AMZN) Deal for Souq.com Reveals Billion-Dollar Market Opportunity

Two Colins from the Street are offering financial savvy from divergent perspectives with regards to Tesla …

Read more

FBR Boosts Price Target For Aurinia Pharmaceuticals Inc (AUPH) As Balance Sheet Improves

FBR analyst Vernon Bernardino, one of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) biggest bulls, is out today with …

Read more

Nike Inc (NKE) Announces Results For The Fiscal Third Quarter Ended February 28, 2017

Nike Inc (NYSE:NKE) reported financial results for its fiscal 2017 third quarter ended February 28, …

Read more

Wall Street Cheers These Two Rising Stocks: Esperion Therapeutics Inc (ESPR) and Nektar Therapeutics (NKTR)

Esperion Therapeutics Inc (NASDAQ:ESPR) and Nektar Therapeutics (NASDAQ:NKTR) are skyrocketing with a fury today on …

Read more

Rosenblatt Sets Expectations On Micron Technology, Inc. (MU) Ahead Of Earnings

With Micron Technology, Inc. (NASDAQ:MU) preparing to release its fiscal second-quarter results this Thursday, March 23, …

Read more

H.C. Wainwright Slashes Catabasis Pharmaceuticals Inc (CATB) Price Target in Half, But Sticks with Buy Rating

Catabasis Pharmaceuticals Inc (NASDAQ:CATB) shares are falling almost 8% amid an unfortunate setback with the …

Read more

Cowen Sees Array Biopharma Inc (ARRY) Share Weakness as Attractive Despite NDA Loss

Array Biopharma Inc (NASDAQ:ARRY) shares are dipping almost 8% after the discouraging news broke that …

Read more

Apple Inc. (AAPL) Services Revenue To Take Off, NVIDIA Corporation (NVDA) Impresses Following DL Connect Conference

It’s a good time to be an investor in Apple Inc. (NASDAQ:AAPL) and NVIDIA Corporation …

Read more